ATXA Therapeutics

Blackrock, Ireland

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Oct 2022

Venture - Series Unknown

Pharmaceutical Therapeutics

Top Investors

Enterprise IrelandEuropean Innovation CouncilEISMEA

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ATXA Therapeutics

Who are ATXA Therapeutics's investors?

ATXA Therapeutics's investors include Enterprise Ireland, European Innovation Council, EISMEA.

Where is ATXA Therapeutics headquartered?

ATXA Therapeutics is headquartered in Blackrock, Ireland.

What does ATXA Therapeutics do?

ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

What stage is ATXA Therapeutics at?

ATXA Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 21, 2022.

MLA

"ATXA Therapeutics — Funding & Investors." VCBacked, October 21, 2022, https://www.vcbacked.co/company/atxa-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). ATXA Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/atxa-therapeutics

Wikipedia (cite web)

{{cite web |title=ATXA Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atxa-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 21, 2022.

Similar Companies in Pharmaceutical